Showing posts with label execedrin. Show all posts
Showing posts with label execedrin. Show all posts

Friday, October 21, 2016

Will Excedrin's debate tweets increase sales?



According to AdWeek, Excedrin won the final presidential debate with their #DebateHeadache sponsored Twitter tweets. 

The first one, which went live at 3 am, said: "The possibility of a #DebateHeadache is high.  Be prepared with Excedrin (R)."  The visual was a photo of the product with the line: "64% of Americans say avoiding headaches is impossible during a presidential election."  You can view all six tweets here...


By the time Wednesday ended, Excedrin had 46,000 Twitter mentions, representing a 3,100% increase versus the previous day.  Mentions spiked by 602% during the debate compared to the hour prior.  (Heine, 2016)

Pretty impressive.  But apparently the promoted trend cost "hundreds of thousands of dollars" and costs were increased further by a scattered overlay of additional promoted tweets.

So the question is, was this a smart move?  Will it translate into increased sales?  Has a tweet ever convinced you to buy something?  If so, what?


Heine, C. (2016, October 20)  Excedrin Won the Debate on Twitter Before It Even Started by Curing Your #DebateHeadache.  adweek.com.  Retrieved October 21, 2016, from